Your browser doesn't support javascript.
loading
IL-33 signaling in sensory neurons promotes dry skin itch.
Trier, Anna M; Mack, Madison R; Fredman, Avery; Tamari, Masato; Ver Heul, Aaron M; Zhao, Yonghui; Guo, Changxiong J; Avraham, Oshri; Ford, Zachary K; Oetjen, Landon K; Feng, Jing; Dehner, Carina; Coble, Dean; Badic, Asima; Joshita, Satoru; Kubo, Masato; Gereau, Robert W; Alexander-Brett, Jennifer; Cavalli, Valeria; Davidson, Steve; Hu, Hongzhen; Liu, Qin; Kim, Brian S.
Afiliación
  • Trier AM; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Mack MR; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Fredman A; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Tamari M; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Ver Heul AM; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Zhao Y; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Guo CJ; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Avraham O; Department of Neuroscience, Washington University School of Medicine, St Louis, Mo.
  • Ford ZK; Department of Anesthesiology and Neuroscience Program, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Oetjen LK; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Feng J; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Dehner C; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Coble D; Division of Biostatistics, Washington University School of Medicine, St Louis, Mo.
  • Badic A; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Joshita S; Division of Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Nagano, Japan.
  • Kubo M; Laboratory of Cytokine Regulation, Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute, Yokohama, Japan; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Tokyo, Japan.
  • Gereau RW; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo; Department of Neuroscience, Washington University School of Medicine, St Louis, Mo; Washington University Pain Center, Washington University School of Medicine, St Louis, Mo.
  • Alexander-Brett J; Division of Pulmonary and Critical Care, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Cavalli V; Department of Neuroscience, Washington University School of Medicine, St Louis, Mo.
  • Davidson S; Department of Anesthesiology and Neuroscience Program, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Hu H; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Liu Q; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
  • Kim BS; Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of
J Allergy Clin Immunol ; 149(4): 1473-1480.e6, 2022 04.
Article en En | MEDLINE | ID: mdl-34560104
ABSTRACT

BACKGROUND:

Chronic pruritus, or itch, is common and debilitating, but the neuroimmune mechanisms that drive chronic itch are only starting to be elucidated. Recent studies demonstrate that the IL-33 receptor (IL-33R) is expressed by sensory neurons. However, whether sensory neuron-restricted activity of IL-33 is necessary for chronic itch remains poorly understood.

OBJECTIVES:

We sought to determine if IL-33 signaling in sensory neurons is critical for the development of chronic itch in 2 divergent pruritic disease models.

METHODS:

Plasma levels of IL-33 were assessed in patients with atopic dermatitis (AD) and chronic pruritus of unknown origin (CPUO). Mice were generated to conditionally delete IL-33R from sensory neurons. The contribution of neuronal IL-33R signaling to chronic itch development was tested in mouse models that recapitulate key pathologic features of AD and CPUO, respectively.

RESULTS:

IL-33 was elevated in both AD and CPUO as well as their respective mouse models. While neuron-restricted IL-33R signaling was dispensable for itch in AD-like disease, it was required for the development of dry skin itch in a mouse model that mirrors key aspects of CPUO pathology.

CONCLUSIONS:

These data highlight how IL-33 may be a predominant mediator of itch in certain contexts, depending on the tissue microenvironment. Further, this study provides insight into future therapeutic strategies targeting the IL-33 pathway for chronic itch.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dermatitis Atópica / Interleucina-33 Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dermatitis Atópica / Interleucina-33 Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article